Enrique A Conterno Eli Lilly & CO (LLY) insider trading activity

Enrique A Conterno is SVP&Pres, LillyDiab & LillyUSA of ELI LILLY & Co. Currently has a direct ownership of 132,962 shares of LLY, which is worth approximately $103 Million. The most recent transaction as insider was on Feb 15, 2019, when has been sold 25,000 shares (Common Stock) at a price of $121.0 per share, resulting in proceeds of $3,025,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 133K

0% 3M change

0% 12M change

Total Value Held $103 Million

Enrique A Conterno Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 15 2019	SELL Open market or private sale	$3,025,000 $121.0 p/Share	25,000 Reduced 15.83%	132,962 Common Stock
Feb 04 2019	BUY Grant, award, or other acquisition	$3,206,256 $120.17 p/Share	26,681 Added 14.45%	157,961 Common Stock
Feb 01 2019	SELL Payment of exercise price or tax liability	$656,353 $119.86 p/Share	5,476 Reduced 4.0%	131,280 Common Stock
Feb 01 2019	BUY Exercise of conversion of derivative security	-	12,222 Added 8.2%	136,756 Common Stock
May 31 2018	SELL Open market or private sale	$2,125,000 $85.0 p/Share	25,000 Reduced 16.72%	124,534 Common Stock
May 01 2018	SELL Payment of exercise price or tax liability	$724,279 $81.07 p/Share	8,934 Reduced 5.64%	149,534 Common Stock
May 01 2018	BUY Exercise of conversion of derivative security	-	20,000 Added 11.21%	158,468 Common Stock
Feb 01 2018	SELL Payment of exercise price or tax liability	$774,752 $81.45 p/Share	9,512 Reduced 6.43%	138,468 Common Stock
Feb 01 2018	BUY Exercise of conversion of derivative security	-	21,326 Added 12.6%	147,980 Common Stock
Jan 29 2018	BUY Grant, award, or other acquisition	$1,089,481 $87.6 p/Share	12,437 Added 8.94%	126,654 Common Stock
May 04 2017	SELL Open market or private sale	$2,069,000 $82.76 p/Share	25,000 Reduced 17.96%	114,217 Common Stock

Also insider at

FGEN

FIBROGEN INC Healthcare

Chief Executive Officer

EAC